Just when Goldman's long-time Novo Nordisk bull James Quigley likely thought the downside was exhausted, the stock plunged yet again on Thursday after tumbling earlier this week following a dismal sales outlook.

Wall Street is extending its slide Thursday, as investors lean into a risk-off attitude amid another selloff in tech and crypto stocks.

If you have been watching Nvidia lately, you have probably noticed the excitement has cooled off. The stock that led the market higher has gone nowhere for months.

The UK's FTSE 100 slipped on Thursday, pressured by a decline in Shell shares after the oil giant reported quarterly profits that fell short of expectations.

Natural gas volatility is almost as crazy as the weather as we should see a record-breaking withdrawal in weekly inventory.

The outlook for the Dutch retail sector is looking bright over the year ahead, with an expected turnover growth of 4.5%. We see increased purchasing power prompting consumers to spend more, both in the high street and in supermarkets.

Barring another glitch in the federal government’s on-again-off-again operating schedule, the delayed report for the fourth-quarter GDP report is set for release in two weeks (Feb. 20).

After rising to an all-time high of 4,025 tonnes in 2025, ETF gold holdings continued to climb in January, growing by another 120.1 tonnes. 

S&P Syndicate Public Company Limited operates a nationwide restaurant and bakery chain in Thailand and internationally.

Gold is not about predicting tops or timing entries. It is about quietly improving portfolio efficiency, reducing drawdowns, and owning something that behaves differently when it actually counts.

Gold consolidates as weak U.S. labor data boosts expectations of Fed easing. Persistent geopolitical tensions and a well-defined long-term uptrend continue to support the bullish case.

After opening lower, the Indian market dragged further as the session progressed and ended the day lower.

Hims & Hers stock rose over 10% after the company unveiled plans to sell a cheaper compounded version of Novo Nordisk’s Wegovy pill.

SPX futures consolidated above the trendline overnight, testing Intermediate resistance at 6810.00.

Initial claims rose 22,000 to 231,000, except for one week the highest since early November.

Markets this week have once again been sending mixed signals, though perhaps not as severe as the crash in precious metals last week.

According to the International Monetary Fund, six of the seven largest developed economies now carry government debt equal to or greater than their annual economic output.

The fall from last week’s spike higher seems to have slowed to nothing, as the price consolidates above $1.1775.

Recent earnings reports reveal mixed performances, with KKR and Cummins Inc. facing challenges, while The Cigna Group surpasses expectations.

The ECB has kept interest rates on hold but points to uncertainty, demonstrating high alertness amid its ongoing wait-and-see stance.